BURLINGTON, MA – October 10, 2025 -- Lifordi Immunotherapeutics, Inc., a biotech company developing antibody drug conjugates (ADCs) for the treatment of autoimmune and inflammatory disorders, will present additional preclinical data on its lead candidate LFD-200, an ADC delive...